Natural Alternatives International, Inc. (NAII) News
Filter NAII News Items
NAII News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NAII News Highlights
- NAII's 30 day story count now stands at 3.
- Over the past 22 days, the trend for NAII's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- EYE are the most mentioned tickers in articles about NAII.
Latest NAII News From Around the Web
Below are the latest news stories about NATURAL ALTERNATIVES INTERNATIONAL INC that investors may wish to consider to help them evaluate NAII as an investment opportunity.
Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time BeingKey Insights Natural Alternatives International to hold its Annual General Meeting on 7th of December CEO Mark LeDoux's... |
Returns On Capital At Natural Alternatives International (NASDAQ:NAII) Paint A Concerning PictureIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a... |
Natural Alternatives International, Inc. Announces 2024 Q1 ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.7 million, or $0.12 per diluted share, on net sales of $34.0 million for the first quarter of fiscal year 2024 compared to net income of $1.1 million, or $0.18 per diluted share, in the first quarter of the prior fiscal year. |
Natural Alternatives International, Inc. Announces 2023 Q4 and YTD ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $2.0 million, or $0.35 per diluted share, on net sales of $35.9 million for the fourth quarter of fiscal year 2023 compared to net income of $3.1 million, or $0.52 per diluted share, in the fourth quarter of the prior fiscal year. |
Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee FurloughsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a temporary closure of its new facility in Carlsbad, California, opened earlier this year to expand NAI's production and add high-speed powder blending and packaging to its manufacturing capabilities, with an initial objective of handling current and estimated orders from one of its largest customers. |
Natural Alternatives International Appoints New VP of Global SalesNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. |
SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to announce that SR CarnoSyn® sustained release beta-alanine has been selected as a finalist in this year's NutraIngredients-USA Awards in two categories: Ingredient of the Year: Healthy Aging and Ingredient of the Year: Cognitive Function. |
Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in CaliforniaNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) today announced the expansion of its global dietary supplement contract manufacturing network, providing the ability to better service existing customers, attract new customers, expand sales, and provide potential for channel and customer diversification. |
Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual MeetingCarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to sponsor Dr. Guilherme G. Artioli and announce that several other leading CarnoSyn® beta-alanine researchers will be presenting at the American College of Sports Medicine and Exercise Science (ACSM) Annual Meeting and World Congresses Conference in Denver, CO on May 30-June 2, 2023. |
Natural Alternatives International, Inc. Announces 2023 Q3 and YTD ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.4 million, or $0.41 per diluted share, on net sales of $32.7 million for the third quarter of fiscal year 2023 compared to net income of $2.5 million, or $0.41 per diluted share, in the third quarter of the prior fiscal year. |